Trial intelligence / Profile preview

PK Study of Oral Testosterone Esters in Hypogonadal Men

NCT02697188Phase 2Completed

Sponsor
Clarus Therapeutics
Start
Nov 2007
Primary completion
Apr 2008
Modality
Hormone, Biologic
Countries
1
01

Overview

A Phase 2 trial of testosterone undecanoate in Hypogonadism, sponsored by Clarus Therapeutics. Started Nov 2007; status: completed.

02

Drugs

testosterone undecanoate
03

Conditions

Hypogonadism

Beyond the preview

Go deeper on NCT02697188.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02697188.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call